As of 2025-09-15, the Fair Value of Edgewise Therapeutics Inc (EWTX) is -7.15 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 14.24 USD, the upside of Edgewise Therapeutics Inc is -150.23%.
With the market price of 14.24 USD and our fair value calculation, Edgewise Therapeutics Inc (EWTX) is not a good investment. Investing in EWTX stocks now will result in a potential loss of 150.23%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -17.12 | -42.81 | -67.64 | -100.16 | -133.81 | -72.31 |
| YoY growth | -76.31% | -150.06% | -58.00% | -48.08% | -33.60% | -73.21% |
| Market Cap (mil) | 1,500.18 |
| P/E | |
| Forward P/E |
| EPS | -1.43 |
| Avg earnings growth rate | -73.21% |
| TTM earnings | -150.70 |